SI0717043T1 - Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators - Google Patents
Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulatorsInfo
- Publication number
- SI0717043T1 SI0717043T1 SI9530352T SI9530352T SI0717043T1 SI 0717043 T1 SI0717043 T1 SI 0717043T1 SI 9530352 T SI9530352 T SI 9530352T SI 9530352 T SI9530352 T SI 9530352T SI 0717043 T1 SI0717043 T1 SI 0717043T1
- Authority
- SI
- Slovenia
- Prior art keywords
- dihydropyridines
- bridged
- potassium channel
- channel modulators
- selective potassium
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Manufacture Of Tobacco Products (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4444860A DE4444860A1 (de) | 1994-12-16 | 1994-12-16 | Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als Arzneimittel |
EP95119052A EP0717043B1 (de) | 1994-12-16 | 1995-12-04 | Verwendung von 1,2-überbrückten 1,4-Dihydropyridinen als selektive Kaliumkanalmodulatoren |
Publications (1)
Publication Number | Publication Date |
---|---|
SI0717043T1 true SI0717043T1 (en) | 2000-02-29 |
Family
ID=6535985
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9530352T SI0717043T1 (en) | 1994-12-16 | 1995-12-04 | Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators |
Country Status (25)
Country | Link |
---|---|
US (2) | US5990121A (es) |
EP (2) | EP0717043B1 (es) |
JP (1) | JPH08239384A (es) |
KR (1) | KR960022517A (es) |
CN (1) | CN1059442C (es) |
AT (1) | ATE186536T1 (es) |
AU (1) | AU709760B2 (es) |
CA (1) | CA2165131A1 (es) |
CZ (1) | CZ332895A3 (es) |
DE (2) | DE4444860A1 (es) |
DK (1) | DK0717043T3 (es) |
EE (1) | EE9500076A (es) |
ES (1) | ES2139824T3 (es) |
FI (1) | FI956016A (es) |
GR (1) | GR3032394T3 (es) |
HU (1) | HUT74166A (es) |
IL (1) | IL116386A (es) |
MX (1) | MX9505097A (es) |
NO (1) | NO955103L (es) |
NZ (1) | NZ280661A (es) |
PL (1) | PL180439B1 (es) |
RU (1) | RU2155765C2 (es) |
SI (1) | SI0717043T1 (es) |
SK (1) | SK158095A3 (es) |
ZA (1) | ZA9510695B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050075359A1 (en) * | 2003-03-14 | 2005-04-07 | Rikako Kono | Large conductance calcium-activated K channel opener |
US7394475B2 (en) * | 2004-02-13 | 2008-07-01 | Infoprint Solutions Company, Llc | Apparatus, system, and method for image registration |
US20070203239A1 (en) * | 2004-06-23 | 2007-08-30 | Neurotec Pharma, S.L. | Compounds For The Treatment Of An Acute Injury To The Central Nervous System |
EP1782812A1 (en) * | 2004-06-23 | 2007-05-09 | Neurotec Pharma, S.L. | Compounds for the treatment of inflammation of the central nervous system |
AU2006203819A1 (en) * | 2005-01-07 | 2006-07-13 | Roskamp Research Llc | Compounds for inhibiting beta-amyloid production and methods of identifying the compounds |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE220633C (es) * | ||||
DE2210674C3 (de) * | 1972-03-06 | 1981-09-24 | Bayer Ag, 5090 Leverkusen | 2-Amino-6-methyl-1,4-dihydropyridine, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel |
US3951988A (en) * | 1972-03-06 | 1976-04-20 | Bayer Aktiengesellschaft | 1,2-Pentamethylene-1,4-dihydropyridine derivatives |
DE2210633C2 (de) * | 1972-03-06 | 1983-09-22 | Bayer Ag, 5090 Leverkusen | Kondensierte Pyridinderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4053614A (en) * | 1972-03-06 | 1977-10-11 | Bayer Aktiengesellschaft | 1,2-pentamethylene-1,4-dihydropyridine derivatives |
US3935220A (en) * | 1972-03-06 | 1976-01-27 | Bayer Aktiengesellschaft | Tetrahydroimidazolo[1,2-a]pyridine derivatives |
US5225566A (en) * | 1992-05-08 | 1993-07-06 | American Home Products Corporation | Indazolanonyl derivative of benzopyran |
-
1994
- 1994-12-16 DE DE4444860A patent/DE4444860A1/de not_active Withdrawn
-
1995
- 1995-12-04 ES ES95119052T patent/ES2139824T3/es not_active Expired - Lifetime
- 1995-12-04 SI SI9530352T patent/SI0717043T1/xx unknown
- 1995-12-04 EP EP95119052A patent/EP0717043B1/de not_active Expired - Lifetime
- 1995-12-04 EP EP99105350A patent/EP0924211A3/de not_active Withdrawn
- 1995-12-04 DK DK95119052T patent/DK0717043T3/da active
- 1995-12-04 AT AT95119052T patent/ATE186536T1/de not_active IP Right Cessation
- 1995-12-04 DE DE59507220T patent/DE59507220D1/de not_active Expired - Fee Related
- 1995-12-06 MX MX9505097A patent/MX9505097A/es unknown
- 1995-12-07 AU AU40294/95A patent/AU709760B2/en not_active Ceased
- 1995-12-08 US US08/569,534 patent/US5990121A/en not_active Expired - Fee Related
- 1995-12-13 NZ NZ280661A patent/NZ280661A/en unknown
- 1995-12-13 JP JP7346244A patent/JPH08239384A/ja active Pending
- 1995-12-13 CA CA002165131A patent/CA2165131A1/en not_active Abandoned
- 1995-12-14 FI FI956016A patent/FI956016A/fi unknown
- 1995-12-14 PL PL95311843A patent/PL180439B1/pl unknown
- 1995-12-14 IL IL11638695A patent/IL116386A/xx not_active IP Right Cessation
- 1995-12-15 RU RU95121078/04A patent/RU2155765C2/ru active
- 1995-12-15 SK SK1580-95A patent/SK158095A3/sk unknown
- 1995-12-15 ZA ZA9510695A patent/ZA9510695B/xx unknown
- 1995-12-15 HU HU9503597A patent/HUT74166A/hu unknown
- 1995-12-15 NO NO955103A patent/NO955103L/no not_active Application Discontinuation
- 1995-12-15 EE EE9500076A patent/EE9500076A/xx unknown
- 1995-12-15 KR KR1019950050396A patent/KR960022517A/ko not_active Application Discontinuation
- 1995-12-15 CN CN95120851A patent/CN1059442C/zh not_active Expired - Fee Related
- 1995-12-15 CZ CZ953328A patent/CZ332895A3/cs unknown
-
1999
- 1999-07-28 US US09/362,409 patent/US6147087A/en not_active Expired - Fee Related
-
2000
- 2000-01-14 GR GR20000400088T patent/GR3032394T3/el not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3317495A (en) | Aroyl-piperidine derivatives | |
ES2112029T3 (es) | Nuevos filtros solares, composiciones cosmeticas fotoprotectoras que los contienen y utilizaciones. | |
GR3032394T3 (en) | Use of 1,2-bridged 1,4-dihydropyridines as selective potassium channel modulators | |
HK1010102A1 (en) | 4-indolylpiperazinyl derivatives | |
AU4585096A (en) | New tricyclic derivatives, their preparation, their use for the preparation of optically active or racemic colchicine and thiocolchicine and analogues or derivatives and intermediates | |
NO972943D0 (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse | |
CA2220536A1 (fr) | Nouveaux derives de filtres silicies sur leur partie aromatique, compositions cosmetiques photoprotectrices les contenant et utilisations | |
AU6193196A (en) | Substituted 4H-pyrans | |
ATE229513T1 (de) | Disubstituierte trans-3,4,4a,5,6,10b-hexahydro-2h-napht(1,2-b)- ,4-oxazine, verfahren zu deren herstellung und diese enthaltende pharmazeutigsche zusammensetzungen | |
DE69837628D1 (de) | Aminderivate, verfahren zu ihrer herstellung und ihre verwendung als antimykotische mittel | |
ATE199897T1 (de) | Aminierte 6,7,8,9-tetrahydro- cyclopenta(a)naphthalen- und 2,3-dihydro- cyclopenta(e)inden-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen | |
ES2059928T3 (es) | Ciclopropanotiocarboxiamidas. | |
NO972942L (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse | |
DK0532725T3 (da) | Isoxazolderivater som lysfilterpræparater | |
HUP9903423A3 (en) | 3-descladinose-2,3-anhydroerythromycin derivatives |